Earnings History Data for Alpine Immune Sciences, Inc. (ALPN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Alpine Immune Sciences, Inc.

Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
18-03-2024	AH		ALPN	Alpine Immune Sciences, Inc.	2,090	0.15	-0.29	-0.41	Alpine Immune Sciences GAAP EPS of -$0.64, revenue of $58.88M [3/18/2024 4:15 PM]	39.88	4.41 (12.45%)	37.28	1.81 (5.10%)	6.39 - 42.24	2,628,530	1,430,000	1,129
Alpine Immune Sciences GAAP EPS of -$0.64, revenue of $58.88M [3/18/2024 4:15 PM]
14-08-2023	AH		ALPN	Alpine Immune Sciences	643.00	-0.27	-0.38	0.00	Alpine Immune Sciences reports Q2 results [8/15/2023 10:31 AM]	13.49	0.24 (1.85%)	13.90	0.65 (4.91%)	4.82 - 14.92	289,589	270,000	580
Alpine Immune Sciences reports Q2 results [8/15/2023 10:31 AM]
23-03-2023	AH	4:05 PM ET (Mar 23)	ALPN	Alpine Immune Sciences, Inc.	379.25	-0.41	-0.34	-0.52	Alpine Immune Sciences GAAP EPS of -$0.41 misses by $0.14, revenue of $2.78M misses by $8.18M [3/23/2023 4:08 PM]	7.42	-0.70 (-8.62%)	8.12	0.0 (0.00%)	4.82 - 9.95	120,682	120,000	2,025
Alpine Immune Sciences GAAP EPS of -$0.41 misses by $0.14, revenue of $2.78M misses by $8.18M [3/23/2023 4:08 PM]
14-11-2022	AH	4:05 PM ET (Nov 14)	ALPN	Alpine Immune Sciences, Inc.	258.76	-0.42	-0.10	-0.55	Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32, revenue of $8.37M misses by $10.31M [11/14/2022 4:23 PM]	6.25	0.51 (8.89%)	5.74	0.0 (0.00%)	4.82 - 14.40	83,149	120,000	12,619
Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32, revenue of $8.37M misses by $10.31M [11/14/2022 4:23 PM] Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2022 Financial Results [Nov-14-22 04:05PM] Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates [Nov-14-22 05:25PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	ALPN	Alpine Immune Sciences	257.00	-0.60	-0.39	0.00	Alpine Immune Sciences GAAP EPS of -$0.60 misses by $0.21, revenue of $5.29M misses by $4.75M [8/11/2022 5:34 PM]	8.80	0.22 (2.56%)	8.51	-0.07 (-0.82%)	6.00 - 14.40	54,769	70,000	3,150
Alpine Immune Sciences GAAP EPS of -$0.60 misses by $0.21, revenue of $5.29M misses by $4.75M [8/11/2022 5:34 PM] Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Results [Aug-11-22 04:05PM] Evotec, Alpine Expand Pact For Commercial Process Development Of Autoimmune Disease Candidate [Aug-10-22 07:54AM] Just Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303 [Aug-10-22 01:30AM]
10-11-2021	AH		ALPN	Alpine Immune Sciences, Inc.	377.90	-0.55	0.00	-0.28	Alpine Immune Sciences EPS misses by $0.56, misses on revenue [11/10/2021 4:42 PM]	12.95	-0.61 (-4.50%)	12.50	-1.06 (-7.82%)	7.70 - 16.37	77,558	60,000	1,000
Alpine Immune Sciences EPS misses by $0.56, misses on revenue [11/10/2021 4:42 PM] Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-10-21 04:05PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	ALPN	Alpine Immune Sciences, Inc.	211.89	-0.46	-0.29	-0.53	Alpine Immune Sciences EPS misses by $0.12, misses on revenue [8/10/2021 4:16 PM]	9.05	-0.14 (-1.52%)	9.19	0.0 (0.00%)	6.66 - 16.37	39,763	50,000	166
Alpine Immune Sciences EPS misses by $0.12, misses on revenue [8/10/2021 4:16 PM] Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-10-21 04:05PM] Alpine Immune Sciences, Inc. (ALPN) Reports Q2 Loss, Tops Revenue Estimates [Aug-10-21 05:45PM]
13-05-2021	AH	4:05 PM ET (May 13)	ALPN	Alpine Immune Sciences, Inc.	286.77	-0.45	-0.32	-0.30	Alpine Immune Sciences EPS misses by $0.09, misses on revenue [5/13/2021 5:17 PM]	11.80	0.32 (2.79%)	0.0	0.0 (0.00%)	2.96 - 16.37	147,320	90,000	0
Alpine Immune Sciences EPS misses by $0.09, misses on revenue [5/13/2021 5:17 PM] Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-13-21 04:05PM] Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Lags Revenue Estimates [May-13-21 06:45PM]
18-03-2021	AH	4:05 PM ET (Mar 18)	ALPN	Alpine Immune Sciences, Inc.	317.30	-0.27	-0.28	-0.33	Alpine Immune Sciences EPS beats by $0.04, beats on revenue [3/18/2021 4:14 PM]	12.72	-1.09 (-7.89%)	13.50	-0.31 (-2.24%)	2.05 - 16.37	192,364	130,000	561
Alpine Immune Sciences EPS beats by $0.04, beats on revenue [3/18/2021 4:14 PM] Alpine Immune Sciences, Inc. to Host Earnings Call [Mar-18-21 02:30PM] Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-18-21 04:05PM] Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates [Mar-18-21 05:35PM] Alpine Immune Sciences, Inc. (ALPN) Q4 2020 Earnings Call Transcript [Mar-19-21 12:00AM]
12-11-2020	AH	4:05 PM ET (Nov 12)	ALPN	Alpine Immune Sciences, Inc.	189.09	-0.28	-0.23	-0.62	Alpine Immune Sciences EPS misses by $0.05, misses on revenue [11/12/2020 4:09 PM]	8.04	-0.12 (-1.53%)	7.75	-0.41 (-5.02%)	2.05 - 15.00	45,537	27,830	392

11-08-2020	AH	4:00 PM ET (Aug 11)	ALPN	Alpine Immune Sciences, Inc.	251.31	-0.53	-0.23	-0.64		9.35	-0.84 (-8.29%)	10.50	0.31 (3.04%)	2.05 - 15.00	133,250	89,449	440

14-05-2020	AH	4:00 PM ET (May 14)	ALPN	Alpine Immune Sciences, Inc.	63.01	-0.30	-0.48	-0.70	Alpine Immune Sciences EPS beats by $0.17, beats on revenue [5/14/2020 4:30 PM]	3.32	0.27 (8.85%)	0.0	0.0 (0.00%)	2.05 - 5.95	29,773	20,054	0